Literature DB >> 3614667

Single-fiber electromyography is a sensitive indicator of axonal degeneration in diabetes.

R W Shields.   

Abstract

Axonal degeneration with reinnervation was assessed in diabetic subjects with single-fiber electromyography (SF-EMG). SF-EMG was performed on 18 control subjects, 20 diabetic control subjects without clinical or electromyographic evidence of polyneuropathy, and 30 diabetic subjects with clinical and electromyographic features of polyneuropathy. In the diabetic controls and diabetic neuropathy subjects, fiber density and jitter were increased indicating axonal degeneration with reinnervation. These findings confirm that axonal degeneration is a principal pathologic mechanism in diabetic polyneuropathy and that axonal degeneration commonly occurs in asymptomatic diabetic subjects. SF-EMG is thus a sensitive method for assessing axonal degeneration in diabetic subjects.

Entities:  

Mesh:

Year:  1987        PMID: 3614667     DOI: 10.1212/wnl.37.8.1394

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P H Hendriksen; P L Oey; G H Wieneke; B Bravenboer; J D Banga
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Accelerated atrophy of lower leg and foot muscles--a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI).

Authors:  C S Andreassen; J Jakobsen; S Ringgaard; N Ejskjaer; H Andersen
Journal:  Diabetologia       Date:  2009-03-12       Impact factor: 10.122

3.  Sequential electrodiagnostic evaluation of diabetic neuropathy after combined pancreatic and renal transplantation.

Authors:  C Vial; X Martin; N Lefrancois; J M Dubernard; F Chauvin; B Bady
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.